{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:56:21Z","timestamp":1790420181651,"version":"4.1.0"},"reference-count":177,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejso.2020.02.012","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T21:35:56Z","timestamp":1582839356000},"page":"11-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":272,"title":["Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment"],"prefix":"10.1016","volume":"47","author":[{"given":"K.","family":"Govaerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Lurvink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.H.J.T.","family":"De Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Van der Speeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kusamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Kepenekian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Deraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Barrios-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almog","family":"Ben-Yaacov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Bertulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Cashin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Cecil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Dayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Goere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuno","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W.","family":"Loggie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faheez","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviram","family":"Nissan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pompiliu","family":"Piso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pocard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Rau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Reymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Sideris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Spiliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.","family":"Sugarbaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J.","family":"Verwaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcom S.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yonemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejso.2020.02.012_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4240\/wjgs.v10.i5.49","article-title":"Approach to pseudomyxoma peritonei","volume":"10","author":"Rizvi","year":"2018","journal-title":"World J Gastrointest Surg"},{"issue":"7","key":"10.1016\/j.ejso.2020.02.012_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/bjs.5385","article-title":"Management of an unexpected appendiceal neoplasm","volume":"93","author":"Murphy","year":"2006","journal-title":"Br J Surg"},{"issue":"12","key":"10.1016\/j.ejso.2020.02.012_bib3","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.ejso.2010.09.004","article-title":"Prospective longitudinal study of quality of life following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"36","author":"Alves","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/01.sla.0000231705.40081.1a","article-title":"Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"245","author":"Smeenk","year":"2007","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1245\/s10434-017-6326-0","article-title":"Long-term quality of life after cytoreductive surgery and heated intraperitoneal chemotherapy for pseudomyxoma peritonei: a prospective longitudinal study","volume":"25","author":"Stearns","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.012_bib6","article-title":"The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on pseudomyxoma peritonei and peritoneal mesothelioma","author":"Lurvink","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A\u00a0consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface Oncology group international (PSOGI) modified Delphi process","volume":"40","author":"Carr","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jso.21054","article-title":"Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei)","volume":"98","author":"Moran","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000052897","article-title":"Pseudomyxoma peritonei: a review of current literature","volume":"51","author":"Sherer","year":"2001","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/PAP.0000000000000178","article-title":"An update on the diagnosis, grading, and staging of appendiceal mucinous neoplasms","volume":"25","author":"Valasek","year":"2018","journal-title":"Adv Anat Pathol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1463-1318.2005.00773.x","article-title":"Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence","volume":"7","author":"Alexander-Sefre","year":"2005","journal-title":"Colorectal Dis"},{"issue":"8","key":"10.1016\/j.ejso.2020.02.012_bib12","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1245\/s10434-007-9393-9","article-title":"Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"14","author":"Baratti","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jso.20107","article-title":"Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix","volume":"87","author":"Carmignani","year":"2004","journal-title":"J\u00a0Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10147-012-0397-5","article-title":"Comparative analysis of perioperative intraperitoneal chemotherapy regimen in appendiceal and colorectal peritoneal carcinomatosis","volume":"18","author":"Chua","year":"2013","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/DCR.0000000000000719","article-title":"Histological subtype remains a significant prognostic factor for survival outcomes in patients with appendiceal mucinous neoplasm with peritoneal dissemination","volume":"60","author":"Huang","year":"2017","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib16","first-page":"173","article-title":"Carbohydrate antigen 19-9 (CA 19-9) is an independent prognostic indicator in pseudomyxoma peritonei post cytoreductive surgery and perioperative intraperitoneal chemotherapy","volume":"4","author":"Koh","year":"2013","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2020.02.012_bib17","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.ejso.2017.09.009","article-title":"CA 19-9 to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with epithelial appendiceal mucinous neoplasms and peritoneal dissemination undergoing cytoreduction surgery and intraperitoneal chemotherapy: a retrospective cohort study","volume":"43","author":"Kozman","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jso.23329","article-title":"Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei","volume":"108","author":"Kusamura","year":"2013","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.012_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2016.02.022","article-title":"Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei","volume":"54","author":"Nummela","year":"2016","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.ejso.2020.02.012_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejso.2013.12.021","article-title":"Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma Peritonei: analysis of 519 patients","volume":"40","author":"Taflampas","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2020.02.012_bib21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/BF02574513","article-title":"Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"9","author":"van Ruth","year":"2002","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2020.02.012_bib22","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/codi.12924","article-title":"Elevated tumour markers are normalized in most patients with pseudomyxoma peritonei 7 days after complete tumour removal","volume":"17","author":"Di Fabio","year":"2015","journal-title":"Colorectal Dis"},{"issue":"7","key":"10.1016\/j.ejso.2020.02.012_bib23","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1245\/s10434-009-0341-8","article-title":"Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution","volume":"16","author":"Chua","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/SLA.0b013e3182602ad2","article-title":"Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy","volume":"256","author":"Chua","year":"2012","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00384-011-1303-8","article-title":"Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome","volume":"27","author":"Chua","year":"2012","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","article-title":"Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis","volume":"16","author":"Koh","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejso.2005.09.016","article-title":"Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"32","author":"de Bree","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2020.02.012_bib28","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1245\/s10434-015-4446-y","article-title":"A\u00a0simplified preoperative assessment predicts complete cytoreduction and outcomes in patients with low-grade mucinous adenocarcinoma of the appendix","volume":"22","author":"Dineen","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib29","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1245\/s10434-017-6275-7","article-title":"Prediction of resectability in pseudomyxoma peritonei with a new CT score","volume":"25","author":"Bouquot","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cncr.20836","article-title":"Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy","volume":"103","author":"Yan","year":"2005","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib31","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1245\/s10434-012-2788-2","article-title":"Surveillance MR imaging is superior to serum tumor markers for detecting early tumor recurrence in patients with appendiceal cancer treated with surgical cytoreduction and HIPEC","volume":"20","author":"Low","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.02.012_bib32","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1245\/s10434-014-4041-7","article-title":"Comparison of MRI and CT for predicting the Peritoneal Cancer Index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures","volume":"22","author":"Low","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ejso.2016.01.005","article-title":"Preoperative CT and MRI prediction of non-resectability in patients treated for pseudomyxoma peritonei from mucinous appendiceal neoplasms","volume":"42","author":"Menassel","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2214\/AJR.07.2018","article-title":"Mucinous appendiceal neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings","volume":"190","author":"Low","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejso.2009.09.001","article-title":"Pseudomyxoma peritonei: role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction","volume":"36","author":"Passot","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2020.02.012_bib36","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s00259-016-3347-z","article-title":"FDG-PET\/ceCT is useful to predict recurrence of Pseudomyxoma peritonei","volume":"43","author":"Dubreuil","year":"2016","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF02587230","article-title":"Clinical experiences at St. Mark's Hospital with multiple synchronous cancers of the colon and rectum","volume":"18","author":"Heald","year":"1975","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.ejso.2020.02.012_bib38","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/bjs.1800770509","article-title":"Metachronous colorectal carcinoma","volume":"77","author":"Bulow","year":"1990","journal-title":"Br J Surg"},{"issue":"11","key":"10.1016\/j.ejso.2020.02.012_bib39","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1007\/s10350-007-9033-2","article-title":"Four percent of patients undergoing colorectal cancer surgery may have synchronous appendiceal neoplasia","volume":"50","author":"Khan","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejso.2020.02.012_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1477-7819-7-51","article-title":"Incidence of synchronous appendiceal neoplasm in patients with colorectal cancer and its clinical significance","volume":"7","author":"Lohsiriwat","year":"2009","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02236899","article-title":"Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies","volume":"41","author":"Connor","year":"1998","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.ejso.2020.02.012_bib42","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1002\/1097-0142(197605)37:5<2511::AID-CNCR2820370544>3.0.CO;2-L","article-title":"Epithelial neoplasms of the vermiform appendix (exclusive of carcinoid). II. Cystadenomas, papillary adenomas, and adenomatous polyps of the appendix","volume":"37","author":"Wolff","year":"1976","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000658-199401000-00009","article-title":"The natural history of surgically treated primary adenocarcinoma of the appendix","volume":"219","author":"Nitecki","year":"1994","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.ejso.2020.02.012_bib44","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ejso.2010.05.025","article-title":"Primary appendiceal carcinoma--epidemiology, surgery and survival: results of a German multi-center study","volume":"36","author":"Benedix","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/bjs.8908","article-title":"Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis","volume":"100","author":"Iversen","year":"2013","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.ejso.2020.02.012_bib46","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00464-003-9139-0","article-title":"Minilaparoscopy in the diagnosis of peritoneal tumor spread: prospective controlled comparison with computed tomography","volume":"18","author":"Denzer","year":"2004","journal-title":"Surg Endosc"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib47","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s13193-015-0486-9","article-title":"Diagnostic laparoscopy in the pre-operative assessment of patients undergoing cytoreductive surgery and HIPEC for peritoneal surface malignancies","volume":"7","author":"Seshadri","year":"2016","journal-title":"Indian J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/ejso.2000.1031","article-title":"Pseudomyxoma peritonei in a hernia sac: analysis of 20 patients in whom mucoid fluid was found during a hernia repair","volume":"27","author":"Esquivel","year":"2001","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/02656736.2017.1338363","article-title":"Diagnostic and therapeutic laparoscopy in assessment and management of patients with appendiceal neoplasms","volume":"34","author":"Tan","year":"2018","journal-title":"Int J Hyperther"},{"issue":"12","key":"10.1016\/j.ejso.2020.02.012_bib50","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1097\/DCR.0b013e3182a62b0d","article-title":"Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved","volume":"56","author":"Dayal","year":"2013","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.ejso.2020.02.012_bib51","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00384-010-1124-1","article-title":"A\u00a0retrospective clinicopathological analysis of appendiceal tumors from 3,744 appendectomies: a single-institution study","volume":"26","author":"Lee","year":"2011","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib52","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000443165","article-title":"ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas)","volume":"103","author":"Pape","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.ejso.2020.02.012_bib53","doi-asserted-by":"crossref","first-page":"782","DOI":"10.5858\/arpa.2013-0047-OA","article-title":"Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: comparison of clinicopathologic features and prognosis","volume":"139","author":"Taggart","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"10.1016\/j.ejso.2020.02.012_bib54","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/modpathol.2016.105","article-title":"Adenocarcinoma ex-goblet cell carcinoid (appendiceal-type crypt cell adenocarcinoma) is a morphologically distinct entity with highly aggressive behavior and frequent association with peritoneal\/intra-abdominal dissemination: an analysis of 77 cases","volume":"29","author":"Reid","year":"2016","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.ejso.2020.02.012_bib55","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/PAS.0000000000001056","article-title":"Histologic and outcome study supports reclassifying appendiceal goblet cell carcinoids as goblet cell adenocarcinomas, and grading and staging similarly to colonic adenocarcinomas","volume":"42","author":"Yozu","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAP.0000000000000222","article-title":"Goblet cell carcinoid\/carcinoma: an update","volume":"26","author":"Zhang","year":"2019","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib57","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1530\/EC-17-0311","article-title":"Goblet cell carcinomas of the appendix: rare but aggressive neoplasms with challenging management","volume":"7","author":"Clift","year":"2018","journal-title":"Endocr Connect"},{"issue":"6","key":"10.1016\/j.ejso.2020.02.012_bib58","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1245\/s10434-013-3469-5","article-title":"Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: an emerging treatment option for advanced goblet cell tumors of the appendix","volume":"21","author":"McConnell","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2020.02.012_bib59","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/bjs.8739","article-title":"Classification of and cytoreductive surgery for low-grade appendiceal mucinous neoplasms","volume":"99","author":"McDonald","year":"2012","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib60","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1245\/s10434-017-6305-5","article-title":"Clinical surveillance after macroscopically complete surgery for low-grade Appendiceal mucinous neoplasms (LAMN) with or without limited peritoneal spread: long-term results in a prospective series","volume":"25","author":"Guaglio","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib61","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12957-016-0996-0","article-title":"Early identification of DPAM in at-risk low-grade appendiceal mucinous neoplasm patients: a new approach to surveillance for peritoneal metastasis","volume":"14","author":"Foster","year":"2016","journal-title":"World J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2020.02.012_bib62","first-page":"4943","article-title":"Strategies for preventing pseudomyxoma peritonei after resection of a mucinous neoplasm of the appendix","volume":"35","author":"Honore","year":"2015","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib63","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1245\/s10434-016-5588-2","article-title":"Low-grade Appendiceal mucinous neoplasm of uncertain malignant potential (LAMN-UMP): prognostic factors and implications for treatment and follow-up","volume":"24","author":"Fournier","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2020.02.012_bib64","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/DCR.0000000000000869","article-title":"Peritoneal involvement is more common than nodal involvement in patients with high-grade Appendix tumors who are undergoing prophylactic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"60","author":"Mehta","year":"2017","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib65","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.suronc.2017.01.006","article-title":"Radical appendectomy as an alternative to right colon resection in patients with epithelial appendiceal neoplasms","volume":"26","author":"Gonzalez-Moreno","year":"2017","journal-title":"Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib66","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/bjs.4393","article-title":"Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding","volume":"91","author":"Gonzalez-Moreno","year":"2004","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib67","first-page":"212","article-title":"Right psoas muscle\/aortoiliac groove recurrence: an unusual anatomic site for progression of epithelial tumors of the appendix","volume":"87","author":"Ortega-Perez","year":"2002","journal-title":"Int Surg"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib68","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tjog.2015.02.009","article-title":"Difficulty in diagnosis and different prognoses between colorectal cancer with ovarian metastasis and advanced ovarian cancer: an empirical study of different surgical adoptions","volume":"56","author":"Lee","year":"2017","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib69","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.5301\/jbm.5000158","article-title":"CEA in evaluation of adnexal mass: retrospective cohort analysis and review of the literature","volume":"30","author":"Sagi-Dain","year":"2015","journal-title":"Int J Biol Markers"},{"issue":"11","key":"10.1016\/j.ejso.2020.02.012_bib70","first-page":"A4331","article-title":"Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis","volume":"58","author":"Sorensen","year":"2011","journal-title":"Dan Med Bull"},{"issue":"1\u20132","key":"10.1016\/j.ejso.2020.02.012_bib71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000217748","article-title":"Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomas","volume":"13","author":"Yedema","year":"1992","journal-title":"Tumour Biol"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jso.2930440207","article-title":"Serum CA 12-5 concentrations and CA 12-5\/CEA ratios in patients with epithelial ovarian cancer","volume":"44","author":"Buamah","year":"1990","journal-title":"J\u00a0Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2020.02.012_bib73","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ejso.2016.12.005","article-title":"Management of an inguinal hernia in patients with pseudomyxoma peritonei","volume":"43","author":"Sugarbaker","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"20","key":"10.1016\/j.ejso.2020.02.012_bib74","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib75","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.sla.0000133183.15705.71","article-title":"Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy","volume":"240","author":"Glehen","year":"2004","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib76","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00000658-199402000-00002","article-title":"Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach","volume":"219","author":"Gough","year":"1994","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.ejso.2020.02.012_bib77","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00384-014-1933-8","article-title":"Comparison of serial debulking and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei of appendiceal origin","volume":"29","author":"Jarvinen","year":"2014","journal-title":"Int J Colorectal Dis"},{"issue":"7","key":"10.1016\/j.ejso.2020.02.012_bib78","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ejso.2016.03.017","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours","volume":"42","author":"Ansari","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2020.02.012_bib79","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1245\/s10434-009-0536-z","article-title":"Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma","volume":"16","author":"Chua","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2020.02.012_bib80","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1245\/s10434-017-5821-7","article-title":"Major postoperative complications are a risk factor for impaired survival after CRS\/HIPEC","volume":"24","author":"Schneider","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2020.02.012_bib81","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ejso.2016.03.014","article-title":"Histological subtype and systemic metastases strongly influence treatment and survival in patients with synchronous colorectal peritoneal metastases","volume":"42","author":"Simkens","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib82","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jso.23784","article-title":"Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology","volume":"111","author":"van Oudheusden","year":"2015","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.02.012_bib83","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1245\/s10434-013-3328-4","article-title":"Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin","volume":"21","author":"Winer","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2020.02.012_bib84","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1463-1318.2009.01947.x","article-title":"Survival of patients with pseudomyxoma peritonei treated by serial debulking","volume":"12","author":"Jarvinen","year":"2010","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ejso.2020.02.012_bib85","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-7819-10-56","article-title":"Small bowel involvement is a prognostic factor in colorectal carcinomatosis treated with complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy","volume":"10","author":"Benizri","year":"2012","journal-title":"World J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2020.02.012_bib86","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0399-8320(05)88175-8","article-title":"Preoperative criteria of incomplete resectability of peritoneal carcinomatosis from non-appendiceal colorectal carcinoma","volume":"29","author":"Elias","year":"2005","journal-title":"Gastroenterol Clin Biol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib87","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jso.21053","article-title":"Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination","volume":"98","author":"Esquivel","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib88","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4251\/wjgo.v2.i1.31","article-title":"Selection of patients and staging of peritoneal surface malignancies","volume":"2","author":"Cotte","year":"2010","journal-title":"World J Gastrointest Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.02.012_bib89","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1245\/s10434-014-4186-4","article-title":"A\u00a0comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion","volume":"22","author":"Downs-Canner","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.02.012_bib90","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1245\/s10434-014-3976-z","article-title":"Impact of distal pancreatectomy on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"22","author":"Doud","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib91","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1245\/s10434-013-3354-2","article-title":"Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"21","author":"Votanopoulos","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib92","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1245\/s10434-011-1820-2","article-title":"HIPEC for peritoneal carcinomatosis: does an associated urologic procedure increase morbidity?","volume":"19","author":"Honore","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2020.02.012_bib93","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1245\/s10434-016-5389-7","article-title":"Advanced pseudomyxoma peritonei requiring gastrectomy to achieve complete cytoreduction results in good long-term oncologic outcomes","volume":"23","author":"Di Fabio","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2020.02.012_bib94","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ejso.2006.03.013","article-title":"Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer","volume":"32","author":"Elias","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib95","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/01.sla.0000255561.87771.11","article-title":"Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases","volume":"245","author":"Kianmanesh","year":"2007","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib96","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jso.24543","article-title":"Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"115","author":"Saxena","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"issue":"27","key":"10.1016\/j.ejso.2020.02.012_bib97","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3748\/wjg.v25.i27.3484","article-title":"Colorectal peritoneal metastases: optimal management review","volume":"25","author":"Juan Manuel Sanchez-Hidalgo","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.ejso.2020.02.012_bib98","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1245\/s10434-014-3987-9","article-title":"Peritoneal surface disease with synchronous hepatic involvement treated with Cytoreductive Surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"22","author":"Randle","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib99","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10434-004-1161-5","article-title":"Lymph node metastasis in epithelial malignancies of the appendix with peritoneal dissemination does not reduce survival in patients treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy","volume":"12","author":"Gonzalez-Moreno","year":"2005","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib100","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1245\/s10434-012-2783-7","article-title":"Right hemicolectomy for mucinous adenocarcinoma of the appendix: just right or too much?","volume":"20","author":"Turaga","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib101","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1245\/s10434-016-5632-2","article-title":"When and when not to perform a right colon resection with mucinous appendiceal neoplasms","volume":"24","author":"Sugarbaker","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib102","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/000313481207800234","article-title":"Right hemicolectomy is not routinely indicated in pseudomyxoma peritonei","volume":"78","author":"Foster","year":"2012","journal-title":"Am Surg"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib103","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF02237479","article-title":"Prophylactic oophorectomy in colorectal carcinoma: preliminary results of a randomized, prospective trial","volume":"41","author":"Young-Fadok","year":"1998","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib104","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1463-1318.2005.00770.x","article-title":"The role of prophylactic oophorectomy in women undergoing surgery for colorectal cancer","volume":"7","author":"Banerjee","year":"2005","journal-title":"Colorectal Dis"},{"issue":"11","key":"10.1016\/j.ejso.2020.02.012_bib105","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/bjs.7196","article-title":"Epidemiology and prognosis of ovarian metastases in colorectal cancer","volume":"97","author":"Segelman","year":"2010","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib106","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/bjs.7303","article-title":"Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal origin","volume":"98","author":"Evers","year":"2011","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib107","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1245\/s10434-012-2623-9","article-title":"Ovarian metastasis is associated with retroperitoneal lymph node relapses in women treated for colorectal peritoneal carcinomatosis","volume":"20","author":"Eveno","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib108","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejso.2016.05.019","article-title":"The role of surgery for unusual sites of metastases from colorectal cancer: a review of the literature","volume":"43","author":"Ribeiro Gomes","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib109","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/bjc.1995.18","article-title":"Ovarian metastases from primary gastrointestinal malignancies: the Royal Marsden Hospital experience and implications for adjuvant treatment","volume":"71","author":"Taylor","year":"1995","journal-title":"Br J Canc"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0090-8258(03)00075-1","article-title":"Metastatic ovarian tumors: a review of 64 cases","volume":"89","author":"Yada-Hashimoto","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2020.02.012_bib111","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/DCR.0000000000000791","article-title":"Risk of ovarian involvement in advanced colorectal or appendiceal tumors involving the peritoneum","volume":"60","author":"Mehta","year":"2017","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"10.1016\/j.ejso.2020.02.012_bib112","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.ejso.2008.03.010","article-title":"The differential response to chemotherapy of ovarian metastases from colorectal carcinoma","volume":"34","author":"Goere","year":"2008","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib113","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygyno.2005.05.028","article-title":"The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries","volume":"98","author":"Ayhan","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib114","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol Med"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib115","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/bjc.2011.250","article-title":"What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primaries","volume":"105","author":"Sasieni","year":"2011","journal-title":"Br J Canc"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib116","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF02523654","article-title":"Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome","volume":"7","author":"Pestieau","year":"2000","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib117","first-page":"372","article-title":"Cytoreductive surgery plus bicavitary chemohyperthermia as treatment of pseudomixoma peritonei with pleural extension. A case report and review of the literature","volume":"85","author":"Saladino","year":"2014","journal-title":"Ann Ital Chir"},{"issue":"10","key":"10.1016\/j.ejso.2020.02.012_bib118","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/0959-8049(96)00178-5","article-title":"Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin","volume":"32A","author":"Zoetmulder","year":"1996","journal-title":"Eur J Canc"},{"issue":"268","key":"10.1016\/j.ejso.2020.02.012_bib119","first-page":"13","article-title":"[Role of the lymphatics of the diaphragm in the absorption of intraperitoneal liquids]","volume":"85","author":"Cheynel","year":"2001","journal-title":"Morphologie"},{"key":"10.1016\/j.ejso.2020.02.012_bib120","first-page":"2016","article-title":"Pseudomyxoma peritonei with intrathoracic extension: a rare disease with rarer presentation from low-grade mucinous adenocarcinoma of the appendix","author":"Ghosh","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"10","key":"10.1016\/j.ejso.2020.02.012_bib121","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/archsurg.2009.166","article-title":"Simultaneous bicavitary hyperthermic chemoperfusion in the management of pseudomyxoma peritonei with synchronous pleural extension","volume":"144","author":"Senthil","year":"2009","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.ejso.2020.02.012_bib122","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/02656736.2017.1300944","article-title":"Haemodynamic changes during hyperthermic intra-thoracic chemotherapy for pseudomyxoma peritonei","volume":"33","author":"Ashraf-Kashani","year":"2017","journal-title":"Int J Hyperther"},{"issue":"12","key":"10.1016\/j.ejso.2020.02.012_bib123","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1245\/s10434-014-3807-2","article-title":"Does obesity affect outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for disseminated mucinous appendiceal neoplasms?","volume":"21","author":"Polanco","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.012_bib124","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1477-7819-10-258","article-title":"Pulmonary influences on early post-operative recovery in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment: a retrospective study","volume":"10","author":"Arakelian","year":"2012","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.012_bib125","doi-asserted-by":"crossref","first-page":"635314","DOI":"10.1155\/2012\/635314","article-title":"Pulmonary complications following cytoreductive surgery and perioperative chemotherapy in 147 consecutive patients","volume":"2012","author":"Preti","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.ejso.2020.02.012_bib126","series-title":"The concept of \u201cobstruction-free survival\u201d as an outcome measure in advanced colorectal cancer management","author":"Moran","year":"2018"},{"issue":"5","key":"10.1016\/j.ejso.2020.02.012_bib127","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1245\/s10434-015-5019-9","article-title":"Can a benefit be expected from surgical debulking of unresectable pseudomyxoma peritonei?","volume":"23","author":"Delhorme","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"15","key":"10.1016\/j.ejso.2020.02.012_bib128","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3748\/wjg.v16.i15.1901","article-title":"Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites","volume":"16","author":"Ba","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ejso.2020.02.012_bib129","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ejso.2006.03.014","article-title":"Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites","volume":"32","author":"Garofalo","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib130","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.sla.0000152015.76731.1f","article-title":"Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy","volume":"241","author":"Miner","year":"2005","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.ejso.2020.02.012_bib131","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/COC.0b013e3181b9cf47","article-title":"Palliative effects of an incomplete cytoreduction combined with perioperative intraperitoneal chemotherapy","volume":"33","author":"Chua","year":"2010","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib132","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/SLA.0b013e31820b4dba","article-title":"Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate","volume":"253","author":"Chua","year":"2011","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib133","first-page":"256","article-title":"Clinical delivery system for intraperitoneal hyperthermic chemotherapy","volume":"40","author":"Spratt","year":"1980","journal-title":"Canc Res"},{"issue":"8","key":"10.1016\/j.ejso.2020.02.012_bib134","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1245\/s10434-008-9967-1","article-title":"A\u00a0phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers","volume":"15","author":"Stewart","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/annonc\/mdf019","article-title":"Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution","volume":"13","author":"Elias","year":"2002","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2020.02.012_bib136","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ejso.2006.03.004","article-title":"Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: pharmacologic studies","volume":"32","author":"Elias","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib137","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000066229","article-title":"Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis","volume":"63","author":"Elias","year":"2002","journal-title":"Oncology"},{"issue":"6","key":"10.1016\/j.ejso.2020.02.012_bib138","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejso.2010.04.005","article-title":"Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study","volume":"36","author":"Pomel","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib139","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00280-014-2525-6","volume":"74","author":"Chalret du Rieu","year":"2014","journal-title":"Canc Chemother Pharmacol"},{"issue":"7","key":"10.1016\/j.ejso.2020.02.012_bib140","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1245\/s10434-016-5143-1","article-title":"Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy with oxaliplatin increases the risk of postoperative hemorrhagic complications: analysis of predictive factors","volume":"23","author":"Charrier","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib141","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000011847","article-title":"Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies","volume":"55","author":"Jacquet","year":"1998","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.ejso.2020.02.012_bib142","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/10611869708995844","article-title":"Pharmacokinetics of mitomycin C (MMC) after intraperitoneal administration of MMC-gelatin gel and its anti-tumor effects against sarcoma-180 bearing mice","volume":"4","author":"Fujita","year":"1997","journal-title":"J\u00a0Drug Target"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib143","first-page":"1165","article-title":"In\u00a0vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C","volume":"40","author":"Barlogie","year":"1980","journal-title":"Canc Res"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib144","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00280-010-1460-4","article-title":"Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis","volume":"68","author":"Van der Speeten","year":"2011","journal-title":"Canc Chemother Pharmacol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib145","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jamcollsurg.2013.12.013","article-title":"Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients","volume":"218","author":"Levine","year":"2014","journal-title":"J\u00a0Am Coll Surg"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib146","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.3747\/co.v18i2.663","article-title":"A\u00a0new standard of care for the management of peritoneal surface malignancy","volume":"18","author":"Mohamed","year":"2011","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ejso.2020.02.012_bib147","article-title":"A\u00a0W. Dose finding study of hyperthermic intraperitoneal chemotherapy with mitomycin C in patients with carcinosis of colorectal origin","volume":"24","year":"1998","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.012_bib148","first-page":"53","article-title":"Experimental and pharmacokinetic studies in intraperitoneal chemotherapy: from laboratory bench to bedside","volume":"169","author":"de Bree","year":"2007","journal-title":"Recent Results Canc Res"},{"issue":"5","key":"10.1016\/j.ejso.2020.02.012_bib149","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1245\/s10434-013-3061-z","article-title":"Consensus guidelines from the American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States","volume":"21","author":"Turaga","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib150","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jamcollsurg.2017.12.027","article-title":"A\u00a0multicenter randomized trial to evaluate hematologic toxicities after hyperthermic intraperitoneal chemotherapy with oxaliplatin or mitomycin in patients with appendiceal tumors","volume":"226","author":"Levine","year":"2018","journal-title":"J\u00a0Am Coll Surg"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib151","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1245\/s10434-016-5529-0","article-title":"Early postoperative intraperitoneal chemotherapy for low-grade Appendiceal mucinous neoplasms with pseudomyxoma peritonei: is it beneficial?","volume":"24","author":"Huang","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2020.02.012_bib152","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ejso.2017.09.002","article-title":"Early postoperative intraperitoneal chemotherapy is associated with survival benefit for appendiceal adenocarcinoma with peritoneal dissemination","volume":"43","author":"Huang","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib153","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.amjsurg.2015.03.008","article-title":"Hyperthermic intraperitoneal chemotherapy\u00a0+ early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis","volume":"210","author":"Lam","year":"2015","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib154","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/02656736.2015.1135485","article-title":"Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference?","volume":"32","author":"Tan","year":"2016","journal-title":"Int J Hyperther"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib155","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1245\/s10434-006-9167-9","article-title":"Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis","volume":"14","author":"Elias","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2020.02.012_bib157","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jso.23547","article-title":"Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"109","author":"Blackham","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib158","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SLA.0b013e31818eec64","article-title":"Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"249","author":"Baratti","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2020.02.012_bib159","doi-asserted-by":"crossref","first-page":"163284","DOI":"10.1155\/2012\/163284","article-title":"Systemic chemotherapy prior to cytoreductive surgery and HIPEC for carcinomatosis from appendix cancer: impact on perioperative outcomes and short-term survival","volume":"2012","author":"Bijelic","year":"2012","journal-title":"Gastroenterol Res Pract"},{"issue":"5","key":"10.1016\/j.ejso.2020.02.012_bib160","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ejso.2015.01.005","article-title":"Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA)","volume":"41","author":"Milovanov","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib161","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/annonc\/mdr279","article-title":"Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix","volume":"23","author":"Lieu","year":"2012","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib162","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1245\/s10434-012-2789-1","article-title":"Assessment of neoadjuvant chemotherapy on operative parameters and outcome in patients with peritoneal dissemination from high-grade appendiceal cancer","volume":"20","author":"Turner","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2020.02.012_bib163","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1634\/theoncologist.2013-0186","article-title":"Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas","volume":"18","author":"Raghav","year":"2013","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib164","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.surg.2012.07.027","article-title":"Predictors of survival in patients with high-grade peritoneal metastases undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"152","author":"Van Sweringen","year":"2012","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib165","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1245\/s10434-007-9691-2","article-title":"Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"15","author":"Baratti","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib166","first-page":"3","article-title":"Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"7","author":"Cummins","year":"2016","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib167","first-page":"783","article-title":"Perioperative systemic chemotherapy for peritoneal mucinous appendiceal carcinomas treated with cytoreductive surgery & HIPEC","volume":"22","author":"Spiliotis","year":"2017","journal-title":"J\u00a0BUON"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib168","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cncr.29744","article-title":"The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: analysis of the National Cancer Data Base","volume":"122","author":"Asare","year":"2016","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib169","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/SLA.0b013e31819ec7e3","article-title":"Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience","volume":"249","author":"Schomas","year":"2009","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12967-016-0877-x","article-title":"GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study","volume":"14","author":"Pietrantonio","year":"2016","journal-title":"J\u00a0Transl Med"},{"issue":"8","key":"10.1016\/j.ejso.2020.02.012_bib171","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1634\/theoncologist.2014-0106","article-title":"FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma","volume":"19","author":"Pietrantonio","year":"2014","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib172","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.bjc.6604522","article-title":"A\u00a0phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei","volume":"99","author":"Farquharson","year":"2008","journal-title":"Br J Canc"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.012_bib173","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/cncr.24715","article-title":"Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience","volume":"116","author":"Shapiro","year":"2010","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.012_bib174","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1200\/jco.2012.30.4_suppl.568","article-title":"Systemic Chemotherapy in the setting of unresectable appendiceal epithelial neoplasms (AEN)","volume":"30","author":"Eng","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2020.02.012_bib175","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1245\/s10434-014-4335-9","article-title":"Improved survival with anti-VEGF therapy in the treatment of unresectable Appendiceal epithelial neoplasms","volume":"22","author":"Choe","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.012_bib176","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejso.2014.08.476","article-title":"Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours","volume":"41","author":"Lord","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.012_bib177","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejso.2016.08.021","article-title":"Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei","volume":"43","author":"Delhorme","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2020.02.012_bib178","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.ejso.2018.06.023","article-title":"Single centre guidelines for radiological follow-up based on 775 patients treated by cytoreductive surgery and HIPEC for appendiceal pseudomyxoma peritonei","volume":"44","author":"Govaerts","year":"2018","journal-title":"Eur J Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320301141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320301141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T16:07:23Z","timestamp":1755274043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320301141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":177,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0748798320301141"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.02.012","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}